CRYSTALLINE FORM OF 1'-(1-METHYLETHYL)-4'-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5'-METHYL-1H-PYRAZOL-3'-O-beta-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS

The invention relates to a crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-beta-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.

Saved in:
Bibliographic Details
Main Authors MARTIN HANS JURGEN, PINNETTI SABINE, STREICHER RUEDIGER, RITTER REGINE, DURAN ADIL, KRAEMER GERD, ADELGOSS GEBHARD, MAIER STEFFEN, THOMAS LEO, SCHILCHER GEBHARD, DUGI KLAUS, EICKELMANN PETER
Format Patent
LanguageEnglish
Published 02.02.2009
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-beta-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
Bibliography:Application Number: KR20087019563